A nationwide survey of co-occurrence of malignant lymphomas and myelodysplastic syndromes/myeloproliferative neoplasms

被引：0
|
作者：
Mamiko Sakata-Yanagimoto
Yasuhisa Yokoyama
Hideharu Muto
Naoshi Obara
Naoki Kurita
Takayasu Kato
Yuichi Hasegawa
Yasushi Miyazaki
Mineo Kurokawa
Shigeru Chiba
机构：
[1] University of Tsukuba,Department of Hematology, Faculty of Medicine
[2] University of Tsukuba Hospital,Department of Hematology
[3] Nagasaki University,Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Graduate School of Biomedical Sciences
[4] The University of Tokyo,Department of Hematology and Oncology, Graduate School of Medicine
来源：
Annals of Hematology | 2016年 / 95卷
关键词：
Follicular Lymphoma; Malignant Lymphoma; Nationwide Survey; Myeloproliferative Neoplasm; Myeloid Malignancy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：829 / 830
页数：1
相关论文
共 50 条
  • [21] Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
    Hebeda K.M.
    Fend F.
    Journal of Hematopathology, 2009, 2 (4) : 205 - 210
  • [22] Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
    Sud, Amit
    Chattopadhyay, Subhayan
    Thomsen, Hauke
    Sundquist, Kristina
    Sundquist, Jan
    Houlston, Richard S.
    Hemminki, Kari
    BLOOD, 2018, 132 (09) : 973 - 976
  • [23] Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes
    M Brecqueville
    N Cervera
    V Gelsi-Boyer
    A Murati
    J Adélaïde
    M Chaffanet
    J Rey
    N Vey
    M J Mozziconacci
    D Birnbaum
    Blood Cancer Journal, 2011, 1 : e18 - e18
  • [24] Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes
    Brecqueville, M.
    Cervera, N.
    Gelsi-Boyer, V.
    Murati, A.
    Adelaide, J.
    Chaffanet, M.
    Rey, J.
    Vey, N.
    Mozziconacci, M. J.
    Birnbaum, D.
    BLOOD CANCER JOURNAL, 2011, 1 : e18 - e18
  • [25] Efficacy and Safety of Danazol in Patients with Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms: A Multicenter Observational Study
    Bosi, Alessandro
    Fattizzo, Bruno
    Rizzo, Lorenzo
    Ferrari, Silvia
    Lussana, Federico
    Borin, Lorenza Maria
    Castelli, Andrea
    Bianchi, Paola
    Barcellini, Wilma
    Cairoli, Roberto
    Molteni, Alfredo
    Riva, Marta
    BLOOD, 2022, 140 : 6925 - 6926
  • [26] Analysis of serum sialyl-Lewisx antigen levels in acute leukemias, myelodysplastic syndromes, myeloproliferative disorders and malignant lymphomas
    Takubo, T
    Shibata, H
    Terada, Y
    Aoyama, Y
    Nakamae, H
    Yamamura, R
    Shima, E
    Makita, K
    Tanaka, K
    Ohta, K
    Yamane, T
    Hino, M
    Hashimoto, S
    Kamitani, T
    Tatsumi, N
    LEUKEMIA & LYMPHOMA, 2002, 43 (09) : 1889 - 1891
  • [27] A Nationwide Survey of Lower Risk Myelodysplastic Syndromes in Japan
    Nakazaki, Kumi
    Takezaki, Toshiaki
    Masamoto, Yosuke
    Miyazaki, Yasushi
    Mitani, Kinuko
    Kurokawa, Mineo
    BLOOD, 2021, 138
  • [28] Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
    Malcovati, Luca
    Papaemmanuil, Elli
    Bowen, David T.
    Boultwood, Jacqueline
    Della Porta, Matteo G.
    Pascutto, Cristiana
    Travaglino, Erica
    Groves, Michael J.
    Godfrey, Anna L.
    Ambaglio, Ilaria
    Galli, Anna
    Da Via, Matteo C.
    Conte, Simona
    Tauro, Sudhir
    Keenan, Norene
    Hyslop, Ann
    Hinton, Jonathan
    Mudie, Laura J.
    Wainscoat, James S.
    Futreal, P. Andrew
    Stratton, Michael R.
    Campbell, Peter J.
    Hellstrom-Lindberg, Eva
    Cazzola, Mario
    BLOOD, 2011, 118 (24) : 6239 - 6246
  • [29] Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms
    Schnittger, S.
    Bacher, U.
    Haferlach, C.
    Alpermann, T.
    Dicker, F.
    Sundermann, J.
    Kern, W.
    Haferlach, T.
    LEUKEMIA, 2011, 25 (04) : 615 - 621
  • [30] Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms
    S Schnittger
    U Bacher
    C Haferlach
    T Alpermann
    F Dicker
    J Sundermann
    W Kern
    T Haferlach
    Leukemia, 2011, 25 : 615 - 621
12345